FDA clears subcutaneous Sarclisa Escena for multiple myeloma, showing comparable overall response rates to IV delivery.
Treating diseases of the esophagus has long posed a frustrating challenge. Medications often pass through too quickly to work ...
Sanofi’s subcutaneous Sarclisa Escena approved in the US as first anticancer treatment administered via on-body injector Sarclisa Escena ...
The US Food and Drug Administration (FDA) recently issued two warning letters to companies for marketing medical devices ...
A man in his late 70s, Albert has always led a full life. From his home in rural Texas, he runs his family farm, oversees ...
Online sales of unapproved peptides are booming, and patients injecting these drugs are increasingly presenting to EDs with ...
Data Safety Monitoring Committee completed initial review of sentinel dosing observations and recommended continued dosing in Cohort 1 - Dosing of additional patients in Cohort 1 is underway at sites ...
Instead, the seemingly botched experiment helped launch a new generation of therapies for autoimmune diseases afflicting ...
ARPA-H gene editing program THRIVE awards $160 million to seven research teams tasked with building scalable base-editing ...
U.S. Department of Health and Human Services (HHS) announced advanced Notice of Termination of the COVID-19 EUA declaration, effective June 29, 2027 ; Consequently, Invivyd receiv ...
After being reported missing, Tatyanna Harrison was discovered dead on a boat in Richmond on May 1, 2022. Photo illustration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results